Disease modification in advanced MS: Focus on upper limb function

Abstract

Get full access to this article

View all access options for this article.

References

Kurtzke

JF.

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33(11): 1444–1452.

Cadavid

Jurgensen

Lee

Impact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting multiple sclerosis. PLoS ONE 2013; 8(1): e53297.

Montalban

Hemmer

Rammohan

et al . Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis: Results of the Phase III double-blind, placebo-controlled ORATORIO study. Neurology 2016; 86(Suppl. 16): S49.001.

Yozbatiran

Baskurt

et al . Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients. J Neurol Sci 2006; 246(1–2): 117–122.

Lamers

Maris

Severijns

et al . Upper limb rehabilitation in people with multiple sclerosis: A systematic review. Neurorehabil Neural Repair 2016; 30(8): 773–793.